Management of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS Syndrome): An Update
Top Cited Papers
- 13 June 2003
- journal article
- review article
- Published by S. Karger AG in Dermatology
- Vol. 206 (4) , 353-356
- https://doi.org/10.1159/000069956
Abstract
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a rather distinct severe adverse drug reaction characterised by skin rash, fever, lymph node enlargement and internal organ involvement. Our aim was to review the available data regarding the management of this probably underrecognised subset of drug reaction. So far, the only undisputed way to treat severe hypersensitivity reactions is prompt withdrawal of the offending drug. The use of systemic corticosteroids remains controversial. The benefit of therapies aimed at accelerating the elimination of the causative drug deserves further studies. In the absence of a well-established therapy, primary and secondary prevention have a key role in the management of DRESS syndrome.Keywords
This publication has 13 references indexed in Scilit:
- Down-regulated IL-5 receptor expression on peripheral blood eosinophils from budesonide-treated children with asthmaAllergy, 2002
- ‘Microdose’ isotretinoinBritish Journal of Dermatology, 2000
- Hazards of therapy with high doses of N ‐acetylcysteine for anticonvulsant‐induced hypersensitivity syndromeBritish Journal of Dermatology, 1998
- Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entitiesArchives of Dermatology, 1996
- Anticonvulsant hypersensitivity syndromeArchives of internal medicine (1960), 1995
- Carbamazepine Hypersensitivity Syndrome: Report of 4 Cases and Review of the LiteratureMedicine, 1995
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndromeArchives of Dermatology, 1991
- Importance of the glutathione cycle in drug metabolismPharmacology & Therapeutics, 1987
- Reversible renal failure and myositis caused by phenytoin hypersensitivityPublished by American Medical Association (AMA) ,1976